HOME › Research Insight › New Product Launches and Agreements Are the Key Growth Strategies in the Global Label-free detection Market
New Product Launches and Agreements Are the Key Growth Strategies in the Global Label-free detection Market
The major players in the label-free detection market are Ametek, Inc. (U.S.), Attana AB (Sweden), Bio-Rad Laboratories, Inc. (U.S.), BiOptix (U.S.), Corning, Inc. (U.S.), Danaher Corporation (U.S.), General Electric Corporation (U.S.), Pall Corporation (U.S.), PerkinElmer (U.S.), Roche (Switzerland), and X-BODY Bioscience (U.S.).
There is a high degree of consolidation in the label-free detection market, with few large players dominating the entire market. High degree of consolidation acts as barrier for entry of new entrants in the market. Moreover, high degree of technological sophistication required to manufacture label-free detection products may act as a deterrent for new entrants.
The global label-free detection industry is in the nascent stage, presenting significant growth potential. Most players in this market are aiming to either diversify their product portfolios or expand their geographic presence to maintain their market shares. During 2011 to 2014, new product launches and agreements were the key strategies followed by major players. The new product launches primarily included instruments and consumables used for label-free detection. For instance, in February 2013, FortBio, a subsidiary of Pall Life Sciences, launched a new Dip and Read Anti-FLAG biosensor for detection of FLAG-tagged proteins on the companys Octet and BLItz instrumentation systems. This product launch was a key addition to the companys label-free device portfolio for protein research and drug development. This strategy was mainly adopted by Attana AB (Sweden), BiOptix (U.S.), Corning, Inc. (U.S.), Pall Corporation (U.S.), PerkinElmer (U.S.), and Roche (Switzerland). Companies adopted these strategies in order to expand their product portfolios and to strengthen their market presence.
The second most key strategy adopted by major players was agreements. The agreement strategy was employed by players to gain immediate technological competency and widen their geographic presence. For instance in January 2011, Attana AB entered into an exclusive distributor agreement with Tecan Group (Switzerland) for distribution of Attanas biosensor instruments and assay technology in North America. The agreement helped company to widen Tecans distribution reach in the commercially important geography. The key players who adopted collaborative partnerships as a growth strategy included Corning, Inc. (U.S.), Pall Corporation (U.S.), PerkinElmer (U.S.), and X-BODY Biosciences (U.S.).
Label-Free Detection Market by Technology (Bio-layer interferometry, Optical waveguide grating technology, Surface Plasmon resonance), Consumables & Instruments, Applications (Lead Generation, Binding Kinetics), End user - Global Forecasts & Trends to 2018
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252